{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:57Z","timestamp":1791260637085,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chemorefractory ovarian cancer patients show extremely poor prognosis. Microtubule-stabilizing Taxol (paclitaxel) is a first-line treatment against ovarian cancer. Despite the close interplay between microtubules and cell adhesion, it remains unknown if chemoresistance alters the way cells adhere to their extracellular environment, a process critical for cancer metastasis. To investigate this, we isolated Taxol-resistant populations of OVCAR3 and SKOV3 ovarian cancer cell lines. Though Taxol-resistant cells neither effluxed more drug nor gained resistance to other chemotherapeutics, they did display increased microtubule dynamics. These changes in microtubule dynamics coincided with faster attachment rates and decreased adhesion strength, which correlated with increased surface \u03b21-integrin expression and decreased focal adhesion formation, respectively. Adhesion strength correlated best with Taxol-sensitivity and was found to be independent of microtubule polymerization but dependent on focal adhesion kinase (FAK), which was up-regulated in Taxol-resistant cells. FAK inhibition also decreased microtubule dynamics to equal levels in both populations, indicating alterations in adhesive signaling are up-stream of microtubule dynamics. Taken together, this work demonstrates that Taxol-resistance dramatically alters how ovarian cancer cells adhere to their extracellular environment causing down-stream increases in microtubule dynamics, providing a therapeutic target that may improve prognosis by not only recovering drug sensitivity, but also decreasing metastasis.<\/jats:p>","DOI":"10.1038\/srep09529","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T09:20:53Z","timestamp":1429262453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Alterations in Ovarian Cancer Cell Adhesion Drive Taxol Resistance by Increasing Microtubule Dynamics in a FAK-dependent Manner"],"prefix":"10.1038","volume":"5","author":[{"given":"Daniel J.","family":"McGrail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niti N.","family":"Khambhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark X.","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithin","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandler P.","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"key":"BFsrep09529_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA. Cancer J. Clin. 60, 277\u2013300 (2010).","journal-title":"CA. Cancer J. Clin."},{"key":"BFsrep09529_CR2","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","volume":"374","author":"BT Hennessy","year":"2009","unstructured":"Hennessy, B. T., Coleman, R. L. & Markman, M. Ovarian cancer. Lancet 374, 1371\u201382 (2009).","journal-title":"Lancet"},{"key":"BFsrep09529_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/IJWH.S7012","volume":"2","author":"S Kumar","year":"2010","unstructured":"Kumar, S. et al. Clinical trials and progress with paclitaxel in ovarian cancer. Int. J. Womens. Health 2, 411\u201327 (2010).","journal-title":"Int. J. Womens. Health"},{"key":"BFsrep09529_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"R Coleman","year":"2013","unstructured":"Coleman, R., Monk, B., Sood, A. & Herzog, T. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 10, 211\u2013224 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"BFsrep09529_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal, R. & Kaye, S. B. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 3, 502\u201316 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep09529_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrc2803","volume":"10","author":"M Kavallaris","year":"2010","unstructured":"Kavallaris, M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 10, 194\u2013204 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep09529_CR7","first-page":"55","volume":"15","author":"SB Horwitz","year":"1993","unstructured":"Horwitz, S. B. et al. Taxol: mechanisms of action and resistance. J. Natl. Cancer Inst. Monogr. 15, 55\u201361 (1993).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"BFsrep09529_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbapap.2008.09.017","volume":"1794","author":"M Di Michele","year":"2009","unstructured":"Di Michele, M. et al. A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim. Biophys. Acta 1794, 225\u201336 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFsrep09529_CR9","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.1073\/pnas.191388598","volume":"98","author":"A Gon\u00e7alves","year":"2001","unstructured":"Gon\u00e7alves, A. et al. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. U. S. A. 98, 11737\u201342 (2001).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep09529_CR10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1172\/JCI119642","volume":"100","author":"M Kavallaris","year":"1997","unstructured":"Kavallaris, M. et al. Taxol-resistant Epithelial Ovarian Tumors Are Associated with Altered Expression of Specific B-Tubulin Isotypes. J. Clin. Invest 100, 1282\u20131293 (1997).","journal-title":"J. Clin. Invest"},{"key":"BFsrep09529_CR11","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1073\/pnas.78.7.4388","volume":"78","author":"F Cabral","year":"1981","unstructured":"Cabral, F. Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin. Proc. Natl. Acad. Sci. 78, 4388\u20134391 (1981).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"BFsrep09529_CR12","doi-asserted-by":"publisher","first-page":"229ra43","DOI":"10.1126\/scitranslmed.3007965","volume":"6","author":"LM Zasadil","year":"2014","unstructured":"Zasadil, L. M. et al. Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles. Sci. Transl. Med. 6, 229ra43\u2013229ra43 (2014).","journal-title":"Sci. Transl. Med."},{"key":"BFsrep09529_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc3080","volume":"11","author":"D Wirtz","year":"2011","unstructured":"Wirtz, D., Konstantopoulos, K. & Searson, P. C. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat. Rev. Cancer 11, 512\u201322 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep09529_CR14","first-page":"277","volume":"31","author":"H Kajiyama","year":"2007","unstructured":"Kajiyama, H. et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int. J. Oncol. 31, 277\u201383 (2007).","journal-title":"Int. J. Oncol."},{"key":"BFsrep09529_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"H Kenny","year":"2008","unstructured":"Kenny, H. & Kaur, S. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest 118, 1367\u20131379 (2008).","journal-title":"J. Clin. Invest"},{"key":"BFsrep09529_CR16","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1242\/jcs.095653","volume":"124","author":"M Vicente-Manzanares","year":"2011","unstructured":"Vicente-Manzanares, M. & Horwitz, A. R. Adhesion dynamics at a glance. J. Cell Sci. 124, 3923\u20137 (2011).","journal-title":"J. Cell Sci."},{"key":"BFsrep09529_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9\u201322 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep09529_CR18","first-page":"196","volume":"63","author":"MJ Arboleda","year":"2003","unstructured":"Arboleda, M. J. et al. Overexpression of AKT2\/Protein Kinase B{beta} Leads to Up-Regulation of {beta}1 Integrins, Increased Invasion and Metastasis of Human Breast and Ovarian Cancer Cells. Cancer Res. 63, 196\u2013206 (2003).","journal-title":"Cancer Res."},{"key":"BFsrep09529_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/gyno.1999.5388","volume":"73","author":"T Strobel","year":"1999","unstructured":"Strobel, T. & Cannistra, S. A. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol. Oncol. 73, 362\u20137 (1999).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep09529_CR20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1158\/0008-5472.CAN-08-2678","volume":"69","author":"JK Slack-Davis","year":"2009","unstructured":"Slack-Davis, J. K., Atkins, K. A., Harrer, C., Hershey, E. D. & Conaway, M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res. 69, 1469\u201376 (2009).","journal-title":"Cancer Res."},{"key":"BFsrep09529_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1593\/neo.08740","volume":"10","author":"C Landen","year":"2008","unstructured":"Landen, C., Kim, T., Lin, Y. & Merritt, W. Tumor-Selective Response to Antibody-Mediated Targeting of \u03b1 v \u03b2 3 Integrin in Ovarian Cancer. Neoplasia 10, 1259\u20131267 (2008).","journal-title":"Neoplasia"},{"key":"BFsrep09529_CR22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1126\/science.1091325","volume":"303","author":"AF Palazzo","year":"2004","unstructured":"Palazzo, A. F., Eng, C. H., Schlaepfer, D. D., Marcantonio, E. E. & Gundersen, G. G. Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. Science 303, 836\u20139 (2004).","journal-title":"Science"},{"key":"BFsrep09529_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1242\/jcs.03497","volume":"121","author":"A Efimov","year":"2008","unstructured":"Efimov, A. et al. Paxillin-dependent stimulation of microtubule catastrophes at focal adhesion sites. J. Cell Sci. 121, 405\u2013405 (2008).","journal-title":"J. Cell Sci."},{"key":"BFsrep09529_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-cellbio-101011-155711","volume":"29","author":"S Etienne-Manneville","year":"2013","unstructured":"Etienne-Manneville, S. Microtubules in cell migration. Annu. Rev. Cell Dev. Biol. 29, 471\u201399 (2013).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFsrep09529_CR25","first-page":"870","volume":"57","author":"D Debernardis","year":"1997","unstructured":"Debernardis, D., Sir\u00e9, E. & Feudis, P. De. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res. 57, 870\u2013874 (1997).","journal-title":"Cancer Res."},{"key":"BFsrep09529_CR26","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(24)29498-2","volume":"298","author":"SH Jang","year":"2001","unstructured":"Jang, S. H., Wientjes, M. G. & Au, J. L. Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J. Pharmacol. Exp. Ther. 298, 1236\u201342 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep09529_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nmeth.1493","volume":"7","author":"A Matov","year":"2010","unstructured":"Matov, A. et al. Analysis of microtubule dynamic instability using a plus-end growth marker. Nat. Methods 7, 761\u20138 (2010).","journal-title":"Nat. Methods"},{"key":"BFsrep09529_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ncb1262","volume":"7","author":"EJ Ezratty","year":"2005","unstructured":"Ezratty, E. J., Partridge, M. A. & Gundersen, G. G. Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat. Cell Biol. 7, 581\u201390 (2005).","journal-title":"Nat. Cell Biol."},{"key":"BFsrep09529_CR29","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1242\/jcs.090563","volume":"124","author":"A Rape","year":"2011","unstructured":"Rape, A., Guo, W. & Wang, Y. Microtubule depolymerization induces traction force increase through two distinct pathways. J. Cell Sci. 124, 4233\u201340 (2011).","journal-title":"J. Cell Sci."},{"key":"BFsrep09529_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12195-013-0316-5","volume":"7","author":"KK Elineni","year":"2013","unstructured":"Elineni, K. K. & Gallant, N. D. Microtubules Mechanically Regulate Cell Adhesion Strengthening Via Cell Shape. Cell. Mol. Bioeng. 7, 136\u2013144 (2013).","journal-title":"Cell. Mol. Bioeng."},{"key":"BFsrep09529_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0960-9822(02)70714-8","volume":"6","author":"A Bershadsky","year":"1996","unstructured":"Bershadsky, A., Chausovsky, A., Becker, E., Lyubimova, A. & Geiger, B. Involvement of microtubules in the control of adhesion-dependent signal transduction. Curr. Biol. 6, 1279\u201389 (1996).","journal-title":"Curr. Biol."},{"key":"BFsrep09529_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1083\/jcb.200308011","volume":"165","author":"MC Subauste","year":"2004","unstructured":"Subauste, M. C. et al. Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 165, 371\u201381 (2004).","journal-title":"J. Cell Biol."},{"key":"BFsrep09529_CR33","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1083\/jcb.153.4.881","volume":"153","author":"KA Beningo","year":"2001","unstructured":"Beningo, K. A., Dembo, M., Kaverina, I., Small, J. V. & Wang, Y. L. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J. Cell Biol. 153, 881\u20138 (2001).","journal-title":"J. Cell Biol."},{"key":"BFsrep09529_CR34","doi-asserted-by":"publisher","first-page":"14845","DOI":"10.1074\/jbc.M606695200","volume":"282","author":"JK Slack-Davis","year":"2007","unstructured":"Slack-Davis, J. K. et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. 282, 14845\u201352 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep09529_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00280-004-0878-y","volume":"55","author":"Z Duan","year":"2005","unstructured":"Duan, Z., Lamendola, D. E., Duan, Y., Yusuf, R. Z. & Seiden, M. V. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines. Cancer Chemother. Pharmacol. 55, 277\u201385 (2005).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFsrep09529_CR36","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1200\/JCO.2001.19.12.2975","volume":"19","author":"PM Fracasso","year":"2001","unstructured":"Fracasso, P. M. et al. Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study. J. Clin. Oncol. 19, 2975\u201382 (2001).","journal-title":"J. Clin. Oncol."},{"key":"BFsrep09529_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ygyno.2003.11.053","volume":"93","author":"RT Penson","year":"2004","unstructured":"Penson, R. T. et al. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol. Oncol. 93, 98\u2013106 (2004).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep09529_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0006-2952(97)83383-7","volume":"53","author":"H Parekh","year":"1997","unstructured":"Parekh, H., Wiesen, K. & Simpkins, H. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochem. Pharmacol. 53, 461\u201370 (1997).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep09529_CR39","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/sj.onc.1206934","volume":"22","author":"GA Orr","year":"2003","unstructured":"Orr, G. A., Verdier-Pinard, P., McDaid, H. & Horwitz, S. B. Mechanisms of Taxol resistance related to microtubules. Oncogene 22, 7280\u201395 (2003).","journal-title":"Oncogene"},{"key":"BFsrep09529_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1083\/jcb.146.5.1033","volume":"146","author":"I Kaverina","year":"1999","unstructured":"Kaverina, I., Krylyshkina, O. & Small, J. V. Microtubule Targeting of Substrate Contacts Promotes Their Relaxation. J. Cell Biol. 146, 1033\u20131043 (1999).","journal-title":"J. Cell Biol."},{"key":"BFsrep09529_CR41","doi-asserted-by":"crossref","unstructured":"Stehbens, S. J. et al. CLASPs link focal-adhesion-associated microtubule capture to localized exocytosis and adhesion site turnover. Nat. Cell Biol. 16, (2014).","DOI":"10.3410\/f.718415303.793499250"},{"key":"BFsrep09529_CR42","first-page":"1725","volume":"2","author":"D Belotti","year":"1996","unstructured":"Belotti, D. et al. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin. Cancer Res. 2, 1725\u201330 (1996).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep09529_CR43","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1091\/mbc.e08-01-0076","volume":"20","author":"KE Michael","year":"2009","unstructured":"Michael, K. E., Dumbauld, D. W., Burns, K. L., Hanks, S. K. & Garc\u00eda, A. J. Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. Mol. Biol. Cell 20, 2508\u201319 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"BFsrep09529_CR44","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1242\/jcs.02531","volume":"118","author":"KJ Salaycik","year":"2005","unstructured":"Salaycik, K. J., Fagerstrom, C. J., Murthy, K., Tulu, U. S. & Wadsworth, P. Quantification of microtubule nucleation, growth and dynamics in wound-edge cells. J. Cell Sci. 118, 4113\u201322 (2005).","journal-title":"J. Cell Sci."},{"key":"BFsrep09529_CR45","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/j.1349-7006.2008.00977.x","volume":"99","author":"A Horiuchi","year":"2008","unstructured":"Horiuchi, A. et al. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer. Cancer Sci. 99, 2532\u20139 (2008).","journal-title":"Cancer Sci."},{"key":"BFsrep09529_CR46","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1091\/mbc.e05-02-0170","volume":"16","author":"N Gallant","year":"2005","unstructured":"Gallant, N., Michael, K. & Garc\u00eda, A. Cell adhesion strengthening: contributions of adhesive area, integrin binding and focal adhesion assembly. Mol. Biol. Cell 16, 4329\u20134340 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"BFsrep09529_CR47","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jbiomech.2006.05.018","volume":"40","author":"ND Gallant","year":"2007","unstructured":"Gallant, N. D. & Garc\u00eda, A. J. Model of integrin-mediated cell adhesion strengthening. J. Biomech. 40, 1301\u20139 (2007).","journal-title":"J. Biomech."},{"key":"BFsrep09529_CR48","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1242\/jcs.045112","volume":"123","author":"MD Schaller","year":"2010","unstructured":"Schaller, M. D. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J. Cell Sci. 123, 1007\u201313 (2010).","journal-title":"J. Cell Sci."},{"key":"BFsrep09529_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ncb1094","volume":"6","author":"DJ Webb","year":"2004","unstructured":"Webb, D. J. et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154\u201361 (2004).","journal-title":"Nat. Cell Biol."},{"key":"BFsrep09529_CR50","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1158\/1078-0432.CCR-05-1728","volume":"11","author":"J Halder","year":"2005","unstructured":"Halder, J. et al. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin. Cancer Res. 11, 8829\u201336 (2005).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep09529_CR51","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/jnci\/djt210","volume":"105","author":"Y Kang","year":"2013","unstructured":"Kang, Y. et al. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J. Natl. Cancer Inst. 105, 1485\u201395 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFsrep09529_CR52","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","volume":"165","author":"A Sood","year":"2004","unstructured":"Sood, A., Coffin, J. & Schneider, G. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am. J. Pathol. 165, 1087\u20131095 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFsrep09529_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nmeth0210-92","volume":"7","author":"G Gundem","year":"2010","unstructured":"Gundem, G. et al. IntOGen: integration and data mining of multidimensional oncogenomic data. Nat. Methods 7, 92\u20133 (2010).","journal-title":"Nat. Methods"},{"key":"BFsrep09529_CR54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1200\/JCO.2011.38.9346","volume":"30","author":"JR Infante","year":"2012","unstructured":"Infante, J. R. et al. Safety, pharmacokinetic and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. J. Clin. Oncol. 30, 1527\u201333 (2012).","journal-title":"J. Clin. Oncol."},{"key":"BFsrep09529_CR55","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cell.2006.05.029","volume":"125","author":"SL Gupton","year":"2006","unstructured":"Gupton, S. L. & Waterman-Storer, C. M. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 125, 1361\u201374 (2006).","journal-title":"Cell"},{"key":"BFsrep09529_CR56","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","volume":"1","author":"M Iwanicki","year":"2011","unstructured":"Iwanicki, M. et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 1, 144\u2013157 (2011).","journal-title":"Cancer Discov."},{"key":"BFsrep09529_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ygyno.2013.12.031","volume":"132","author":"JM Scalici","year":"2014","unstructured":"Scalici, J. M. et al. Inhibition of \u03b14\u03b21 integrin increases ovarian cancer response to carboplatin. Gynecol. Oncol. 132, 455\u201361 (2014).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep09529_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-0-387-74039-3_6","volume":"608","author":"MM Zutter","year":"2007","unstructured":"Zutter, M. M. Integrin-mediated adhesion: tipping the balance between chemosensitivity and chemoresistance. Adv. Exp. Med. Biol. 608, 87\u2013100 (2007).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFsrep09529_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/01.COC.0000054894.64867.80","volume":"27","author":"F Oshita","year":"2004","unstructured":"Oshita, F. et al. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Am. J. Clin. Oncol. 27, 215\u20139 (2004).","journal-title":"Am. J. Clin. Oncol."},{"key":"BFsrep09529_CR60","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1038\/onc.2010.107","volume":"29","author":"D Lane","year":"2010","unstructured":"Lane, D., Goncharenko-Khaider, N., Rancourt, C. & Pich\u00e9, A. Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation. Oncogene 29, 3519\u201331 (2010).","journal-title":"Oncogene"},{"key":"BFsrep09529_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ygyno.2005.02.006","volume":"98","author":"JA Smith","year":"2005","unstructured":"Smith, J. A., Ngo, H., Martin, M. C. & Wolf, J. K. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol. Oncol. 98, 141\u20135 (2005).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep09529_CR62","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.yexcr.2012.11.017","volume":"319","author":"DJ McGrail","year":"2013","unstructured":"McGrail, D. J., McAndrews, K. M. & Dawson, M. R. Biomechanical analysis predicts decreased human mesenchymal stem cell function before molecular differences. Exp. Cell Res. 319, 684\u201396 (2013).","journal-title":"Exp. Cell Res."},{"key":"BFsrep09529_CR63","doi-asserted-by":"publisher","first-page":"e72457","DOI":"10.1371\/journal.pone.0072457","volume":"8","author":"SL Eaton","year":"2013","unstructured":"Eaton, S. L. et al. Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One 8, e72457 (2013).","journal-title":"PLoS One"},{"key":"BFsrep09529_CR64","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1021\/pr1011476","volume":"10","author":"C Welinder","year":"2011","unstructured":"Welinder, C. & Ekblad, L. Coomassie staining as loading control in Western blot analysis. J. Proteome Res. 10, 1416\u20139 (2011).","journal-title":"J. Proteome Res."},{"key":"BFsrep09529_CR65","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/S0021-9258(19)67891-9","volume":"266","author":"A Minotti","year":"1991","unstructured":"Minotti, A., Barlow, S. & Cabral, F. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J. Biol. Chem. 266, 3987\u20133994 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFsrep09529_CR66","doi-asserted-by":"publisher","first-page":"e33248","DOI":"10.1371\/journal.pone.0033248","volume":"7","author":"DJ McGrail","year":"2012","unstructured":"McGrail, D. J., Ghosh, D., Quach, N. D. & Dawson, M. R. Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors. PLoS One 7, e33248 (2012).","journal-title":"PLoS One"},{"key":"BFsrep09529_CR67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nmeth.1237","volume":"5","author":"K Jaqaman","year":"2008","unstructured":"Jaqaman, K., Loerke, D. & Mettlen, M. Robust single-particle tracking in live-cell time-lapse sequences. Nat. Methods 5, 695\u2013702 (2008).","journal-title":"Nat. Methods"},{"key":"BFsrep09529_CR68","doi-asserted-by":"crossref","unstructured":"McGrail, D. J., Mezencev, R., Kieu, Q. M. N., McDonald, J. F. & Dawson, M. R. SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression. FASEB J. 10.1096\/fj.14-257345 (2014).","DOI":"10.1096\/fj.14-257345"},{"key":"BFsrep09529_CR69","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1242\/jcs.144378","volume":"127","author":"DJ McGrail","year":"2014","unstructured":"McGrail, D. J., Kieu, Q. M. N. & Dawson, M. R. The malignancy of metastatic ovarian cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK pathway. J. Cell Sci. 127, 2621\u20136 (2014).","journal-title":"J. Cell Sci."},{"key":"BFsrep09529_CR70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1529\/biophysj.107.113670","volume":"94","author":"B Sabass","year":"2008","unstructured":"Sabass, B., Gardel, M. L., Waterman, C. M. & Schwarz, U. S. High resolution traction force microscopy based on experimental and computational advances. Biophys. J. 94, 207\u201320 (2008).","journal-title":"Biophys. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep09529","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep09529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep09529.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T13:51:07Z","timestamp":1747921867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep09529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,8,14]]}},"alternative-id":["BFsrep09529"],"URL":"https:\/\/doi.org\/10.1038\/srep09529","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,17]]},"assertion":[{"value":"30 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9529"}}